Basic Information
RNALocate ID: RLID:01001240
RNA Symbol: hsa-let-7e-5p
Localization: Nucleus
RNA Information
RNA Name: hsa-let-7e
RNA ID: miRBase:MIMAT0000066
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 22058130
Tissue/Cell Line: HeLa cells
Method: Next-generation RNA sequencing
Description: Here, we present a data set excluding these RNA before sequencing through locked nucleic acids (LNA), greatly increasing pre-miRNA sequence counts with no discernable effect on pre-miRNA or mature miRNA sequencing. Analysis of profiles generated in total, nuclear and cytoplasmic cell fractions reveals that pre-miRNAs are subject to a wide range of regulatory processes involving loci-specific 3'- and 5'-end variation entailing complex cleavage patterns with co-occurring polyuridylation. Data were collected from Supplementary Table S2, S3.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001230 Cytoplasm Nasopharyngeal carcinoma cells 20498841
RLID:01001231 Cytoplasm Cell line (HeLa) 21695135
RLID:01001232 Cytoplasm HeLa cells 22058130
RLID:01001233 Cytoplasm Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001234 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:01001235 Mitochondrion Cell line (HEK-293|HeLa) 22984580
RLID:01001236 Nucleus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001237 Nucleolus Myoblasts 19628621
RLID:01001238 Nucleolus Breast adenocarcinoma cells (MCF-7) 24918059
RLID:01001239 Nucleus Nasopharyngeal carcinoma cells 20498841
RLID:11000626 Apoptotic body Human umbilical vein endothelial cells 19996457
RLID:11000627 Exosome Primary ovarian tumor cells|Serum 18589210
RLID:11000628 Exosome Hetastatic gastric cancer cell line (AZ-P7a) 20949044
RLID:11000629 Exosome Breast cancer cell line (MCF-7) 20976003
RLID:11000630 Exosome Primary dendritic cells 21505438
RLID:11000631 Exosome Breast milk 22211110
RLID:11000632 Exosome Epidermal melanocytes (HEMa-LP) 23056502
RLID:11000633 Exosome Brain tissue 23382797
RLID:11000634 Exosome Plasma 23663360
RLID:11000635 Exosome K562 cells 24460325
RLID:11000636 Exosome Breast cancer cell lines (MCF-7|MDA-MB-231) 24468161
RLID:11000637 Extracellular vesicle HEK-293T cells 22849433
RLID:11000638 Microvesicle Plasma 23077538
RLID:11000639 Microvesicle Seminal plasma 23539611
RLID-D:11000005 Exosome Endothelial cells|Epithelial cells|Mast cells|Seminal fluid
RLID-D:11000265 Microvesicle Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-let-7e-5p Diffuse large b cell lymphoma MNDR-E-MI-01439
MNDR hsa-let-7e-5p Splenic marginal zone lymphoma MNDR-E-MI-01440
MNDR hsa-let-7e-5p Colorectal adenoma MNDR-E-MI-01441
MNDR hsa-let-7e-5p Oral squamous cell carcinoma MNDR-E-MI-01442
MNDR hsa-let-7e-5p Lymphoma non-hodgkin MNDR-E-MI-01443
MNDR hsa-let-7e-5p Estrogen-receptor positive breast cancer MNDR-E-MI-01444
MNDR hsa-let-7e-5p Estrogen-receptor negative breast cancer MNDR-E-MI-01445
MNDR hsa-let-7e-5p Progesterone-receptor positive breast cancer MNDR-E-MI-01446
MNDR hsa-let-7e-5p Progesterone-receptor negative breast cancer MNDR-E-MI-01447
MNDR hsa-let-7e-5p Breast cancer luminal MNDR-E-MI-01448
MNDR hsa-let-7e-5p Prostate cancer MNDR-E-MI-01449
MNDR hsa-let-7e-5p Gastric cancer MNDR-E-MI-01450
MNDR hsa-let-7e-5p Gastric lymphoma MNDR-E-MI-01451
MNDR hsa-let-7e-5p Alzheimer disease MNDR-E-MI-01452
MNDR hsa-let-7e-5p Dysautonomia familial MNDR-E-MI-01453
MNDR hsa-let-7e-5p Head and neck cancer MNDR-E-MI-01454
MNDR hsa-let-7e-5p Leukemia MNDR-E-MI-01455
MNDR hsa-let-7e-5p Cardiovascular disease MNDR-E-MI-01456
MNDR hsa-let-7e-5p Lung cancer MNDR-E-MI-01457
MNDR hsa-let-7e-5p Metabolic syndrome x MNDR-E-MI-01458
MNDR hsa-let-7e-5p Parkinson disease MNDR-E-MI-01459
MNDR hsa-let-7e-5p Colonic adenomas MNDR-E-MI-01460
MNDR hsa-let-7e-5p Basal-like breast cancer MNDR-E-MI-01461
MNDR hsa-let-7e-5p Thyroid cancer MNDR-E-MI-01462
MNDR hsa-let-7e-5p Pancreatic cancer MNDR-E-MI-01463
MNDR hsa-let-7e-5p Melanoma MNDR-E-MI-01464
MNDR hsa-let-7e-5p Nephroblastoma MNDR-E-MI-01465
MNDR hsa-let-7e-5p Colon cancer MNDR-E-MI-01466
MNDR hsa-let-7e-5p Ischemic attack transient MNDR-E-MI-01467
MNDR hsa-let-7e-5p Colon adenocarcinoma MNDR-E-MI-01468
MNDR hsa-let-7e-5p Familial ovarian cancer MNDR-E-MI-01469
MNDR hsa-let-7e-5p Prostate adenocarcinoma MNDR-E-MI-01470
MNDR hsa-let-7e-5p Carcinoma ductal breast MNDR-E-MI-01471
MNDR hsa-let-7e-5p Glioblastoma MNDR-E-MI-01472
MNDR hsa-let-7e-5p Malignant glioma MNDR-E-MI-01473
MNDR hsa-let-7e-5p Chordoma MNDR-E-MI-01474
MNDR hsa-let-7e-5p Amyotrophic lateral sclerosis MNDR-E-MI-01475
MNDR hsa-let-7e-5p Temporal lobe epilepsy MNDR-E-MI-01476
MNDR hsa-let-7e-5p Osteosarcoma MNDR-E-MI-01477
MNDR hsa-let-7e-5p Liver cancer MNDR-E-MI-01478
MNDR hsa-let-7e-5p Uterine cancer MNDR-E-MI-01479
MNDR hsa-let-7e-5p Cervical adenocarcinoma MNDR-E-MI-01480
MNDR hsa-let-7e-5p Gastric adenocarcinoma MNDR-E-MI-01481
MNDR hsa-let-7e-5p Lung squamous cell carcinoma MNDR-E-MI-01482
MNDR hsa-let-7e-5p Lung adenocarcinoma MNDR-E-MI-01483
MNDR hsa-let-7e-5p Adrenocortical cancer MNDR-E-MI-01484
MNDR hsa-let-7e-5p Thyroid carcinoma MNDR-E-MI-01485
MNDR hsa-let-7e-5p Pancreatic adenocarcinoma MNDR-E-MI-01486
MNDR hsa-let-7e-5p Kidney renal clear cell carcinoma MNDR-E-MI-01487
MNDR hsa-let-7e-5p Kidney renal papillary cell carcinoma MNDR-E-MI-01488
MNDR hsa-let-7e-5p Renal clear cell carcinoma MNDR-E-MI-01489
MNDR hsa-let-7e-5p Biliary tract cancer MNDR-E-MI-01490
MNDR hsa-let-7e-5p Cholangiocarcinoma MNDR-E-MI-01491
MNDR hsa-let-7e-5p Esophageal cancer MNDR-E-MI-01492
MNDR hsa-let-7e-5p Liver cirrhosis MNDR-E-MI-01493
MNDR hsa-let-7e-5p Synovial sarcoma MNDR-E-MI-01494
MNDR hsa-let-7e-5p Head and neck squamous cell carcinoma MNDR-E-MI-01495
MNDR hsa-let-7e-5p Adenoma MNDR-E-MI-01496
MNDR hsa-let-7e-5p Breast invasive carcinoma MNDR-E-MI-01497
MNDR hsa-let-7e-5p Early hepatocellular carcinoma MNDR-E-MI-01498
MNDR hsa-let-7e-5p Familiar ovarian carcinoma MNDR-E-MI-01499
MNDR hsa-let-7e-5p B-cell lymphoma MNDR-E-MI-01500
MNDR hsa-let-7e-5p Rheumatoid arthritis MNDR-E-MI-01501
MNDR hsa-let-7e-5p T-cell leukemia MNDR-E-MI-01502
MNDR hsa-let-7e-5p Retinoblastoma MNDR-E-MI-01503
MNDR hsa-let-7e-5p Neuroblastoma MNDR-E-MI-01504
MNDR hsa-let-7e-5p Hodgkin lymphoma MNDR-E-MI-01505
MNDR hsa-let-7e-5p Burkitt lymphoma MNDR-E-MI-01506
MNDR hsa-let-7e-5p Tonsil cancer MNDR-E-MI-01507
MNDR hsa-let-7e-5p Neuromyelitis optica MNDR-E-MI-01508
MNDR hsa-let-7e-5p Acute myelogenous leukemia MNDR-E-MI-01509
MNDR hsa-let-7e-5p Colorectal cancer MNDR-E-MI-01510
MNDR hsa-let-7e-5p Nasopharynx carcinoma MNDR-E-MI-01511
MNDR hsa-let-7e-5p Multiple myeloma MNDR-E-MI-01512
MNDR hsa-let-7e-5p Nasopharyngeal cancer MNDR-E-MI-01513
MNDR hsa-let-7e-5p Prostatic neoplasms MNDR-E-MI-01514
MNDR hsa-let-7e-5p Epstein-barr virus infections MNDR-E-MI-01515
MNDR hsa-let-7e-5p Cerebral hemorrhage traumatic MNDR-E-MI-01516
MNDR hsa-let-7e-5p Intracranial hemorrhage hypertensive MNDR-E-MI-01517
MNDR hsa-let-7e-5p Stroke MNDR-E-MI-01518
MNDR hsa-let-7e-5p Stroke lacunar MNDR-E-MI-01519
MNDR hsa-let-7e-5p Duke C MNDR-E-MI-01520
MNDR hsa-let-7e-5p Low grade dysplastic nodule MNDR-E-MI-01521
MNDR hsa-let-7e-5p Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-01522
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ACVR1B Homo sapiens RR00038913
TOP